RH (NYSE:RH) on Thursday reported mixed second-quarter fiscal 2026 results. Several analysts revised the price forecast for the company following the results release.
TD Cowen analyst Max Rakhlenko maintained a Buy rating and lowered the price target from $220 to $190.
Wells Fargo analyst Zachary Fadem kept an Overweight rating and slashed the price target from $225 to $175.
UBS analyst Michael Lasser reiterated a Neutral rating and cut the price target from $155 to $154.
BofA Securities analyst Christopher Nardone retained an Underperform rating and trimmed the price target from $156 to $114.






